<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105115</url>
  </required_header>
  <id_info>
    <org_study_id>H-1612-099-815</org_study_id>
    <nct_id>NCT03105115</nct_id>
  </id_info>
  <brief_title>Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine Infusion</brief_title>
  <official_title>Effect of Intrathecal Fentanyl on Spinal Anesthesia During Dexmedetomidine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intravenous infusion of dexmedetomidine during procedure was known to be associated prolonged
      duration of spinal anesthesia. In patients receiving dexmedetomidine infusion during
      procedure, it has been not evaluated whether use of adjuvant intrathecal fentanyl had
      additional prolonging effect on duration of spinal anesthesia or not. Therefore, the
      investigators planned this trial to compare clinical outcomes in patients receiving spinal
      anesthesia with heavy bupivacaine only and heavy bupivacaine plus fentanyl adjuvant.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 25, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2017</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Two segment sensory block regression time</measure>
    <time_frame>From completion of spinal anesthesia, to end of surgery, an expected average of 2 hours</time_frame>
    <description>Time from highest sensory block level to two segment regression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>motor block</measure>
    <time_frame>From completion of spinal anesthesia, to end of surgery, an expected average of 2 hours</time_frame>
    <description>modified Bromage scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain score</measure>
    <time_frame>at op day, at postoperative 1st day, at postoperative 2nd day</time_frame>
    <description>VAS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative nausea and vomiting</measure>
    <time_frame>at op day, at postoperative 1st day, at postoperative 2nd day</time_frame>
    <description>VAS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intraoperative incidence of hypotension</measure>
    <time_frame>From completion of spinal anesthesia, to end of surgery, an expected average of 2 hours</time_frame>
    <description>hypotension : SBP decreased by more than 30% of baseline SBP</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Anesthesia, Spinal</condition>
  <arm_group>
    <arm_group_label>intrathecal fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>heavy bupivacaine 14mg and fentanyl 20mcg will be injected intrathecally during spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>bupivacaine only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>heavy bupivacaine 14mg will be injected intrathecally during spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <description>intrathecal fentanyl will be added as adjuvant for spinal anesthesia using heavy bupivacaine, while dexmedetomidine will be infused intravenously during operation</description>
    <arm_group_label>intrathecal fentanyl</arm_group_label>
    <other_name>Hana Pharmacy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine only</intervention_name>
    <description>heavy bupivacaine will be injected intrathecally during spinal anesthesia, without fentanyl, while dexmedetomidine will be infused intravenously during operation</description>
    <arm_group_label>bupivacaine only</arm_group_label>
    <other_name>AstraZeneca</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients undergoing total knee replacement arthroplasty under spinal anesthesia

        Exclusion Criteria:

          -  Contraindication of spinal anesthesia

          -  inability to communicate

          -  morbid obesity (BMI &gt; 30kg/m2)

          -  spine abnormality

          -  severe cardiac dysfunction

          -  Height &lt;155cm, or &gt; 180cm

          -  contraindication to fentanyl
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-tae Kim</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-tae Kim</last_name>
    <phone>82-2-2072-0694</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sun-Kyung Park, MD.</last_name>
      <phone>+82 2072 2499</phone>
      <email>mayskpark@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Seetharam KR, Bhat G. Effects of isobaric ropivacaine with or without fentanyl in subarachnoid blockade: A prospective double-blind, randomized study. Anesth Essays Res. 2015 May-Aug;9(2):173-7. doi: 10.4103/0259-1162.152149.</citation>
    <PMID>26417123</PMID>
  </reference>
  <reference>
    <citation>Singh R, Kundra S, Gupta S, Grewal A, Tewari A. Effect of clonidine and/or fentanyl in combination with intrathecal bupivacaine for lower limb surgery. J Anaesthesiol Clin Pharmacol. 2015 Oct-Dec;31(4):485-90. doi: 10.4103/0970-9185.169069.</citation>
    <PMID>26702205</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>fentanyl</keyword>
  <keyword>dexmedetomidine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

